 <!--program start-->
        <div class="col-md-12 mt-2">
            <div class="tab" role="tabpanel">
                <!-- Nav tabs -->
              <div class="row">
                  <div class="col-md-9 col-sm-12">
                    <ul class="nav nav-tabs" role="tablist">
                    <li role="presentation" class="active"><a href="<?php echo base_url();?>program/day1" aria-controls="home" role="tab" data-toggle="tab">Day 1, Friday 19<sup>th</sup> April 2019</a></li>
                    <li role="presentation"><a href="<?php echo base_url();?>program/day2" aria-controls="profile" role="tab" data-toggle="tab">Day 2, Saturday 20<sup>th</sup> April 2019</a></li>
                     <li role="presentation" class="active"><a href="<?php echo base_url();?>program/day3" aria-controls="profile" role="tab" data-toggle="tab">Day 3, Sunday 21<sup>st</sup> April 2019</a></li>
                </ul>
                <!-- Tab panes -->
                  </div>
                  <div class="col-md-3 col-sm-12">
                    <a href="<?php echo base_url();?>assets/conference/Conference_Brochure.pdf" target="_blank"><button class="btn btn-info text-center">Download pdf</button></a>
                  </div>
                </div>
                <!-- Tab panes -->
                <div class="tab-content tabs">
                    <div role="tabpanel" class="tab-pane  in active" id="Section1">
                      <!--session 1 start-->
                      <div class="section-tab">
                        <h3><span class="year">08.00 - 09.00</span> Session 6 : Proffered Papers</h3>
                        <h4><span class="year">09.00 - 09.20</span>PSOGI International Guidelines for Pseudomyxoma Peritonei and Mesothelioma </h4>
                      </div>
                      <!--session 1 end-->
                      <!-- session 2 start-->
                      <div class="section-tab">
                        <h3><span class="year">09.20 - 10.40</span> Session 7 : Current Evidence for CRS & HIPEC in Colorectal, Gastric & Ovarian Cancers</h3>
                        <span class="time">09.20 - 09.30</span>
                        <div class="title-border">
                          <p><i class="fa fa-check-square-o" aria-hidden="true"></i>PRODIGE 7 & ProphyloCHIP  </p>
                        </div>
                        <span class="time">09.30 - 09.40</span>
                        <div class="title-border">
                          <p><i class="fa fa-check-square-o" aria-hidden="true"></i>COLOPEC & COMBATAC</p>
                        </div>
                        <span class="time">09.40 - 09.50</span>
                        <div class="title-border">
                          <p><i class="fa fa-check-square-o" aria-hidden="true"></i> GASTRIPEC & GASTRICHIP</p>
                        </div>
                        <span class="time">09.50 - 10.00</span>
                        <div class="title-border">
                          <p><i class="fa fa-check-square-o" aria-hidden="true"></i> OVHIPEC & TBD</p>
                        </div>
                          <h4 class="panel-discussion"><span class="year">10.00 - 10.40</span>Panel Discussion on Current Evidence for CRS & HIPEC in Colorectal, Gastric & Ovarian Cancers</h4>
                          <h4 class="break-sessions"><span class="year">10.40 - 11.00</span> Tea/Coffee Break</h4>
                      </div>
                      <!--session 2 end-->
                      <!-- session 3 start-->
                      <div class="section-tab">
                        <h3><span class="year">11.00 - 12.30</span>Session 8 : Technical Intricacies of CRS & HIPEC</h3>
                        <h4 class="panel-discussion"><span class="year">11.00 - 11.35</span> Panel Discussion : Imaging and Laparoscopic Evaluation before CRS & HIPEC </h4>
                        <span class="time">11.35 - 11.50</span>
                        <div class="title-border">
                          <p><i class="fa fa-check-square-o" aria-hidden="true"></i> Challenges in Anaesthetic Management in HIPEC</p>
                        </div>
                        <span class="time">11.50- 12.30</span>
                        <div class="title-border">
                          <p><i class="fa fa-check-square-o" aria-hidden="true"></i> HIPEC: Procedural Nuances (Kidney protection- Sodium Thiosulphate, Ideal temperature, non-visible mets- ICG, prophylactic stoma)</p>
                        </div>
                      </div>
                      <!--session 3 end-->
                      <!-- session 4 start-->
                      <div class="section-tab">
                        <h3><span class="year">12.30 - 13.00</span>Conference Inaugration</h3>
                      
                          <h4 class="break-sessions"><span class="year">13.00 - 13.45</span>Lunch Break</h4>
                      </div>
                      <!--session 4 end-->
                      <!-- session 5 start-->
                      <div class="section-tab">
                        <h3><span class="year">13.45 - 14.25</span>Session 9 : Chemotherapy in HIPEC</h3>
                        <span class="time">13.45 - 14.05</span>
                        <div class="title-border">
                          <p><i class="fa fa-check-square-o" aria-hidden="true"></i>Chemotherapy Regimens in HIPEC </p>
                        </div>
                        <span class="time">14.05 - 14.25</span>
                        <div class="title-border">
                          <p><i class="fa fa-check-square-o" aria-hidden="true"></i> PIPEC: Rationale, Indications, Preliminary Outcomes(Capnomed Sponsored Talk)</p>
                        </div>
                      </div>
                      <!--session 5 end-->
                      <!-- session 6 start-->
                      <div class="section-tab">
                        <h3><span class="year">14.25 - 15.35</span>Session 10 :  Road to Enhanced Recovery </h3>
                        <span class="time">14.25 - 14.40</span>
                        <div class="title-border">
                          <p><i class="fa fa-check-square-o" aria-hidden="true"></i>ERAS in Peritoneal Surface Malignancies</p>
                        </div>
                        <span class="time">14.40 - 14.55</span>
                        <div class="title-border">
                          <p><i class="fa fa-check-square-o" aria-hidden="true"></i>Supplemental PN in Surgical Patients</p>
                        </div>
                        <span class="time">14.55 - 15.10</span>
                        <div class="title-border">
                          <p><i class="fa fa-check-square-o" aria-hidden="true"></i> How to Reduce Post-Operative Complications?</p>
                        </div>
                        <span class="time">15.10 - 15.25</span>
                        <div class="title-border">
                          <p><i class="fa fa-check-square-o" aria-hidden="true"></i>Where are the dangers in HIPEC?</p>
                        </div>
                        <span class="time">15.25 - 15.35</span>
                        <div class="title-border">
                          <p><i class="fa fa-check-square-o" aria-hidden="true"></i> Q&A: Chairpersons & Speakers</p>
                        </div>
                          <h4 class="break-sessions"><span class="year">15.35 - 15.50</span>Tea/Coffee Break
                          </h4>
                      </div>
                      <!--session 6 end-->
                      <!-- session 7 start-->
                      <div class="section-tab">
                        <h3><span class="year">15.50 - 16.40</span>Session 11:  Indian Experience with HIPEC</h3>
                        <span class="time">15.50 - 16.00</span>
                        <div class="title-border">
                          <p><i class="fa fa-check-square-o" aria-hidden="true"></i>Manipal Comprehensive Cancer Center, Bengaluru</p>
                        </div>
                        <span class="time">16.00 - 16.10</span>
                        <div class="title-border">
                          <p><i class="fa fa-check-square-o" aria-hidden="true"></i> Rajiv Gandhi Cancer Center, New Delhi</p>
                        </div>
                        <span class="time">16.10 - 16.20</span>
                        <div class="title-border">
                          <p><i class="fa fa-check-square-o" aria-hidden="true"></i> All India Institute of Medical Sciences, New Delhi</p>
                        </div>
                        <span class="time">16.20 - 16.30</span>
                        <div class="title-border">
                          <p><i class="fa fa-check-square-o" aria-hidden="true"></i> Fortis Memorial Research Institute, Gurugram </p>
                        </div>
                        <span class="time">16.30 - 16.40</span>
                        <div class="title-border">
                          <p><i class="fa fa-check-square-o" aria-hidden="true"></i> Indian RCT: Welcome Trial on IP and HIPEC </p>
                        </div>
                      </div>
                      <!--session 7 end-->
                      <!--session 13 start-->
                        <div class="section-tab">
                        <h3><span class="year">16.40 - 18.40</span> Session 12: Industry Symposium </h3>
                        <h4><span class="year">16.40 - 17.00</span>CORE DIAGNOSTICS</h4>
                        <span class="time">16.40 - 17.00</span>
                        <div class="title-border">
                          <p><i class="fa fa-check-square-o" aria-hidden="true"></i>Genomics & next generation sequencing</p>
                        </div>
                      </div>
                      <!--session 13 end-->
                      <!--others start-->
                      <div class="section-tab">
                        <h4><span class="year">17.00 - 17.50</span> Astrazeneca </h4>
                        <span class="time">17.00 - 17.20</span>
                        <div class="title-border">
                          <p><i class="fa fa-check-square-o" aria-hidden="true"></i> PARP Inhibition in Ovarian Cancer </p>
                        </div>
                         <h4 class="panel-discussion"><span class="year">17.20 - 17.50</span> Panel Discussion</h4>

                        <h4><span class="year">17.50 - 18.10</span> POSITIVE BIOSCIENCES/MYRIAD </h4>
                        <span class="time">17.50 - 18.10</span>
                        <div class="title-border">
                          <p><i class="fa fa-check-square-o" aria-hidden="true"></i> BRCA testing – Indian scenario Myriad</p>
                        </div>
                        <h3><span class="year">18.00 - 18.40</span> ISPSM GBM </h3>
                      </div>
                      <!--others end-->
                      <!--others1 start-->
                       <div class="section-tab">
                        <h3 class="break-sessions"><span class="year">19.30 onwards</span> Cultural Program & Dinner</h3>
                      </div>
                      <!--others2 end-->
                    </div>
                </div>
            </div>
        </div>
      <!--program end-->
